Dark Light

ABVIDA TRIO 100/10/500MG TABLET 10S – Your Daily Dose for Diabetic Management.


MARKETER
Abbott Healthcare Private Limited
SALT COMPOSITION
Dapagliflozin (10mg) + Metformin (500mg) + Sitagliptin (100mg)

Key Features and Benefits:

  • Triple-action: Meticulously crafted with Dapagliflozin, Metformin, and Sitagliptin, the Trio tablet offers a broad-spectrum solution for managing Type-2 Diabetes.
  • Effective Blood Sugar Control: Ensures effective control of both fasting and postprandial sugar levels.
  • Improved Metabolism: Promotes effective carbohydrate metabolism, ensuring optimal energy utilization.
  • Weight Management: Helps in maintaining weight, a crucial factor in managing diabetes.

166.20

Compare

Product Introduction:

ABVIDA TRIO 100/10/500MG TABLET is a combination medication used for the treatment of type 2 diabetes mellitus. This medication combines three different classes of antidiabetic agents, each with its own mechanism of action, to help manage blood sugar levels.

ABVIDA TRIO 100/10/500MG TABLET can be taken with or without food at any time of the day but try to take it at the same time every day. The dose will be decided by your doctor, so don’t stop taking it without asking them. If you do, your blood sugar levels may increase your risk of serious complications like kidney damage and blindness. This medicine is only a part of the treatment program that should include a healthy diet, regular exercise, and weight reduction as advised by your doctor.

The most common side effects of this medicine include urinary tract infection, nasal congestion, sore throat, and upper respiratory tract infection. Drinking plenty of fluids while using it will help prevent dehydration. Some people may develop fungal infections in the genital area. Maintaining good hygiene can help prevent this.

Before taking ABVIDA TRIO 100/10/500MG TABLET, inform your doctor if you have any kidney or liver problems, a urinary tract infection, or you are on water pills (diuretics). Pregnant or breastfeeding women should also consult their doctor before taking it. Avoid excessive alcohol intake while taking this medicine, as this may increase the risk of some side effects. Monitor your blood sugar levels regularly while taking this medicine.

Uses:

The combination medication is prescribed to individuals with type 2 diabetes to improve glycemic control. It addresses multiple aspects of glucose metabolism, targeting insulin sensitivity, glucose production, and glucose reabsorption in the kidneys.

Benefits:

  1. Blood Sugar Control: The combination of Dapagliflozin, Metformin, and Sitagliptin works synergistically to lower blood sugar levels.
  2. Weight Management: Dapagliflozin, one of the components, is associated with a reduction in body weight.

Side Effects:

As with any medication, there can be potential side effects. Common side effects associated with the components may include:

  • Nausea or stomach upset (Metformin)
  • Genital or urinary tract infections (Dapagliflozin)
  • Upper respiratory tract infection (Sitagliptin)
  • Diarrhea (Metformin and Sitagliptin)

Serious side effects are rare but can include:

  • Lactic acidosis (Metformin): This is a potential but rare side effect, particularly in individuals with impaired kidney function.

Drug Interactions:

The combination of Dapagliflozin, Metformin, and Sitagliptin may interact with other medications. It’s crucial to inform your healthcare provider about all the drugs you are taking, including prescription, over-the-counter, vitamins, and herbal supplements. This helps to avoid potential drug interactions and ensure the safety and efficacy of the treatment.

Dosage:

Dosage recommendations will be determined by a healthcare professional based on the individual’s specific needs, medical history, and response to treatment. The typical dosage for ABVIDA TRIO 100/10/500MG TABLET is taken orally, and patients should adhere to the prescribed dosage and administration instructions.

Working Mechanism:

  • Dapagliflozin (10mg): It is a sodium-glucose co-transporter 2 (SGLT2) inhibitor, reducing glucose reabsorption in the kidneys and increasing urinary glucose excretion.
  • Metformin (500mg): It improves insulin sensitivity, reduces glucose production by the liver, and decreases intestinal glucose absorption.
  • Sitagliptin (100mg): It is a dipeptidyl peptidase-4 (DPP-4) inhibitor, increasing the concentration of incretin hormones, which leads to increased insulin release and decreased glucagon levels.

This combination therapy provides a comprehensive approach to managing type 2 diabetes by addressing various pathways involved in glucose regulation. It is important to use this medication under the guidance of a healthcare professional who can monitor for side effects and adjust the treatment plan as needed.

SAFETY ADVICE

warnings

Alcohol

CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol withABVIDA TRIO 100/10/500MG Tablet. Please consult your doctor.
warnings

Pregnancy

CONSULT YOUR DOCTOR
Information regarding the use of ABVIDA TRIO 100/10/500MG TABLET during pregnancy is not available. Please consult your doctor.
warnings

Breast feeding

CONSULT YOUR DOCTOR
Information regarding the use of ABVIDA TRIO 100/10/500MG TABLET during breastfeeding is not available. Please consult your doctor.
warnings

Driving

CONSULT YOUR DOCTOR
It is not known whether ABVIDA TRIO 100/10/500MG TABLET alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
warnings

Kidney

CONSULT YOUR DOCTOR
There is limited information available on the use of ABVIDA TRIO 100/10/500MG TABLET in patients with kidney disease. Please consult your doctor.
warnings

Liver

CONSULT YOUR DOCTOR
There is limited information available on the use of ABVIDA TRIO 100/10/500MG TABLET in patients with liver disease. Please consult your doctor.

Category:
Weight 0.5 kg
Dimensions 10 × 10 × 10 cm
Open chat
Hello
Can we help you?